» Authors » Scott Janis

Scott Janis

Explore the profile of Scott Janis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 1661
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adeoye O, Broderick J, Derdeyn C, Grotta J, Barsan W, Bentho O, et al.
N Engl J Med . 2024 Sep; 391(9):810-820. PMID: 39231343
Background: Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an antiplatelet agent) are...
2.
Marchina S, Yeatts S, Foster L, Janis S, Shoamanesh A, Khatri P, et al.
Cerebrovasc Dis . 2024 Mar; PMID: 38493765
Introduction: The benefits and risks of HMG-CoA reductase inhibitor (statin) drugs in survivors of intracerebral hemorrhage (ICH) are unclear. Observational studies suggest an association between statin use and increased risk...
3.
Gurol M, Wright C, Janis S, Smith E, Gokcal E, Reddy V, et al.
Stroke . 2023 Dec; 55(1):214-225. PMID: 38134262
Nonvalvular atrial fibrillation is a common rhythm disorder of middle-aged to older adults that can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants reduces the risk of...
4.
Naidech A, Grotta J, Elm J, Janis S, Dowlatshahi D, Toyoda K, et al.
Int J Stroke . 2021 Aug; 17(7):806-809. PMID: 34427473
Introduction: Intracerebral hemorrhage is the deadliest form of stroke. Hematoma expansion, growth of the hematoma between the baseline computed tomography scan and a follow-up computed tomography scan at 24 ± ...
5.
Cramer S, Le V, Saver J, Dodakian L, See J, Augsburger R, et al.
Neurology . 2021 Feb; 96(14):e1812-e1822. PMID: 33589538
Objective: To evaluate the effect of intensive rehabilitation on the modified Rankin Scale (mRS), a measure of activities limitation commonly used in acute stroke studies, and to define the specific...
6.
Cramer S, Wolf S, Saver J, Johnston K, Mocco J, Lansberg M, et al.
Stroke . 2021 Feb; 52(3):1154-1161. PMID: 33563009
No abstract available.
7.
Deeds S, Barreto A, Elm J, Derdeyn C, Berry S, Khatri P, et al.
Int J Stroke . 2020 Dec; 16(7):873-880. PMID: 33297893
Background: Intravenous recombinant tissue plasminogen activator is the only proven effective medication for the treatment of acute ischemic stroke. Two approaches that may augment recombinant tissue plasminogen activator thrombolysis and...
8.
Johnston K, Bruno A, Pauls Q, Hall C, Barrett K, Barsan W, et al.
JAMA . 2019 Jul; 322(4):326-335. PMID: 31334795
Importance: Hyperglycemia during acute ischemic stroke is common and is associated with worse outcomes. The efficacy of intensive treatment of hyperglycemia in this setting remains unknown. Objectives: To determine the...
9.
Cramer S, Dodakian L, Le V, See J, Augsburger R, McKenzie A, et al.
JAMA Neurol . 2019 Jun; 76(9):1079-1087. PMID: 31233135
Importance: Many patients receive suboptimal rehabilitation therapy doses after stroke owing to limited access to therapists and difficulty with transportation, and their knowledge about stroke is often limited. Telehealth can...
10.
Ziai W, McBee N, Lane K, Lees K, Dawson J, Vespa P, et al.
Int J Stroke . 2019 Apr; 14(5):548-554. PMID: 30943878
Rationale And Hypothesis: Surgical removal of spontaneous intracerebral hemorrhage may reduce secondary destruction of brain tissue. However, large surgical trials of craniotomy have not demonstrated definitive improvement in clinical outcomes....